Andréa Martini

1.2k total citations
57 papers, 457 citations indexed

About

Andréa Martini is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Andréa Martini has authored 57 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 16 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Andréa Martini's work include Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Andréa Martini is often cited by papers focused on Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Andréa Martini collaborates with scholars based in Italy, United States and Germany. Andréa Martini's co-authors include Patrizia Pontisso, Paolo Angeli, Carmine Gambino, Salvatore Piano, Alessandra Biasiolo, Mariagrazia Ruvoletto, Giuseppe Gorini, Angelo Gatta, Roberto Vettor and Elisabetta Chellini and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Andréa Martini

51 papers receiving 436 citations

Peers

Andréa Martini
Anya Burton United Kingdom
Caro Noake United Kingdom
Laura Tribus Romania
Kai Dai China
Raghuram Reddy United States
Annie Hung United States
Han‐Ik Cho South Korea
Tami Wisniewski United States
Anya Burton United Kingdom
Andréa Martini
Citations per year, relative to Andréa Martini Andréa Martini (= 1×) peers Anya Burton

Countries citing papers authored by Andréa Martini

Since Specialization
Citations

This map shows the geographic impact of Andréa Martini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andréa Martini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andréa Martini more than expected).

Fields of papers citing papers by Andréa Martini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andréa Martini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andréa Martini. The network helps show where Andréa Martini may publish in the future.

Co-authorship network of co-authors of Andréa Martini

This figure shows the co-authorship network connecting the top 25 collaborators of Andréa Martini. A scholar is included among the top collaborators of Andréa Martini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andréa Martini. Andréa Martini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prete, Salvatore Del, et al.. (2025). Predictors of Persistent Disease Activity and Damage in Systemic Sclerosis. JCR Journal of Clinical Rheumatology. 31(8). e175–e182.
2.
Ruvoletto, Mariagrazia, Santina Quarta, Alessandra Biasiolo, et al.. (2025). The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma. Translational Oncology. 57. 102413–102413.
3.
Pontisso, Patrizia, et al.. (2024). SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives. Cancers. 16(14). 2579–2579. 2 indexed citations
4.
Luisetto, Roberto, Marco Scarpa, Gianmarco Villano, et al.. (2024). 1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition. International Journal of Molecular Sciences. 25(21). 11662–11662.
5.
Zanatta, Elisabetta, Andréa Martini, Mariele Gatto, et al.. (2024). Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 43(2). 269–275. 1 indexed citations
6.
Martini, Andréa, Tyler Zemla, Fowsiyo Ahmed, et al.. (2024). SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma. Cancers. 16(1). 225–225. 2 indexed citations
7.
Martini, Andréa, et al.. (2024). Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population. Internal and Emergency Medicine. 19(3). 641–647.
8.
Zanatta, Elisabetta, Andréa Martini, Marta Tonello, et al.. (2023). CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies. Diagnostics. 13(10). 1715–1715. 7 indexed citations
9.
Martini, Andréa, Cristian Turato, Stefania Cannito, et al.. (2023). The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation. Alimentary Pharmacology & Therapeutics. 59(3). 380–392. 2 indexed citations
10.
Martini, Andréa, et al.. (2023). Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma. Cancers. 15(14). 3629–3629. 5 indexed citations
11.
Donghia, Rossella, Andréa Martini, Pasqua Letizia Pesole, et al.. (2023). Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(22). 16485–16485. 11 indexed citations
12.
Martini, Andréa, Patricia L. Guerra, Simone Incicco, et al.. (2023). The impact of the onset of Hepatocellular Carcinoma on the natural history of cirrhosis. Digestive and Liver Disease. 55. S212–S212. 1 indexed citations
13.
Liu, Hao, Christof Kaltenmeier, Naudia Jonassaint, et al.. (2022). The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States. HPB. 24(11). 1994–2005. 3 indexed citations
14.
Zorzi, Alessandro, Francesco Cardaioli, Francesca D’Arcangelo, et al.. (2021). Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation. International Journal of Cardiology. 339. 219–224. 10 indexed citations
15.
Tonon, Marta, S. Rosi, Carmine Gambino, et al.. (2020). Natural history of acute kidney disease in patients with cirrhosis. Journal of Hepatology. 74(3). 578–583. 46 indexed citations
16.
Bezzini, Daiana, Andréa Martini, Monica Ulivelli, et al.. (2020). Mortality trend for multiple sclerosis in Italy during the period 1980–2015. Multiple Sclerosis and Related Disorders. 44. 102240–102240. 4 indexed citations
17.
Villano, Gianmarco, Alberto Verardo, Andréa Martini, et al.. (2019). Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3. Annals of Hepatology. 19(1). 36–43. 1 indexed citations
18.
Turato, Cristian, Stefania Cannito, Gianmarco Villano, et al.. (2015). SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity. Scientific Reports. 5(1). 17701–17701. 31 indexed citations
19.
Chellini, Elisabetta, et al.. (2015). Malignant Mesotheliomas in Textile Rag Sorters. The Annals of Occupational Hygiene. 59(5). 547–53. 4 indexed citations
20.
Martini, Andréa. (2015). Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World Journal of Hepatology. 7(29). 2913–2913. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026